Corvax

N/A

Report date: 2025/01/26 19:23:43

Base Information

Drug NameCorvax

Drug Alias NameCOVID-19 vaccine (Vaxil BioTherapeutics)SARS-CoV-2 vaccine (Vaxil)protein subunit vaccine (Vaxil)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVaxil Bio therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesVaxil Bio therapeutics

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A